Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-04 Sale |
2025-02-05 4:02 pm |
Arbutus Biopharma Corp | ABUS | Sims Karen Chief Medical Officer |
19,348 | $3.283 | $63,519 | 106,194 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 7:55 pm |
Arbutus Biopharma Corp | ABUS | Sims Karen Chief Medical Officer |
4,358 | $2.3125 | $10,078 | 529,442 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-14 Option Award |
2025-02-19 6:25 pm |
N/A 2035-02-14 |
Arbutus Biopharma Corp | ABUS | Sims Karen Chief Medical Officer |
249,600 | $0 | 355,794 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:55 pm |
N/A 2034-02-01 |
Arbutus Biopharma Corp | ABUS | Sims Karen Chief Medical Officer |
504,900 | $0 | 529,442 (Direct) |
View |
| 2023-07-10 Option Award |
2023-07-12 4:50 pm |
N/A 2033-07-10 |
Arbutus Biopharma Corp | ABUS | Sims Karen Chief Medical Officer |
153,640 | $0 | 153,640 (Direct) |
View |
Ownership |
2023-07-12 4:48 pm |
N/A N/A |
Arbutus Biopharma Corp | ABUS | Sims Karen Chief Medical Officer |
0 | $0 | 317,460 (Direct) |
View |